144 related articles for article (PubMed ID: 35658376)
1. [Risk factors for development of hematotoxicity in elderly patients treated with Linezolid].
Bo SY; Su AM; Yang F; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):533-538. PubMed ID: 35658376
[No Abstract] [Full Text] [Related]
2. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia.
Onita T; Ishihara N; Ikebuchi A; Yano T; Nishimura N; Tamaki H; Ikawa K; Morikawa N; Naora K
J Clin Pharm Ther; 2022 Dec; 47(12):2041-2048. PubMed ID: 35893441
[TBL] [Abstract][Full Text] [Related]
4. Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days.
Sato Y; Iguchi M; Kato Y; Morioka H; Hirabayashi A; Tetsuka N; Tomita Y; Kato D; Yamada K; Kimura H; Yagi T
Nagoya J Med Sci; 2020 Aug; 82(3):407-414. PubMed ID: 33132425
[TBL] [Abstract][Full Text] [Related]
5. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y
J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446
[TBL] [Abstract][Full Text] [Related]
7. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
[TBL] [Abstract][Full Text] [Related]
8. Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case-control study.
Chen C; Li Y; Yu J; Qian S
Clin Transl Oncol; 2022 Mar; 24(3):540-545. PubMed ID: 34716540
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study.
Tsutsumi T; Imai S; Kashiwagi H; Sato Y; Sugawara M; Takekuma Y
Eur J Clin Pharmacol; 2022 Feb; 78(2):279-286. PubMed ID: 34581841
[TBL] [Abstract][Full Text] [Related]
10. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia.
Tanaka R; Suzuki Y; Morinaga Y; Iwao M; Takumi Y; Hashinaga K; Tatsuta R; Hiramatsu K; Kadota JI; Itoh H
J Clin Pharm Ther; 2021 Apr; 46(2):343-351. PubMed ID: 33016566
[TBL] [Abstract][Full Text] [Related]
11. Effect of linezolid on platelet count in critically ill patients with thrombocytopenia.
Tatsumi H; Akatsuka M; Kuroda H; Kazuma S; Suzuki S; Masuda Y
PLoS One; 2023; 18(6):e0286088. PubMed ID: 37384758
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
Mori N; Kamimura Y; Kimura Y; Hirose S; Aoki Y; Bito S
Eur J Clin Pharmacol; 2018 Apr; 74(4):405-411. PubMed ID: 29222713
[TBL] [Abstract][Full Text] [Related]
13. Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.
Tajima M; Kato Y; Matsumoto J; Hirosawa I; Suzuki M; Takashio Y; Yamamoto M; Nishi Y; Yamada H
Biol Pharm Bull; 2016; 39(11):1846-1851. PubMed ID: 27803456
[TBL] [Abstract][Full Text] [Related]
14. Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report.
Xiao B; Deng P; Jin H; Wang H; Cao Y
Am J Case Rep; 2018 Sep; 19():1117-1120. PubMed ID: 30232318
[TBL] [Abstract][Full Text] [Related]
15. [Verification of Relationship between Administration of Linezolid and Vomiting].
Tsutsumi T; Imai S; Yamada K; Yamada T; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2019; 139(7):1055-1061. PubMed ID: 31257252
[TBL] [Abstract][Full Text] [Related]
16. Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System.
Dai Y; Wang Y; Zeng Y; Zhang C; Zhou Z; Shi D
J Clin Pharm Ther; 2020 Dec; 45(6):1422-1426. PubMed ID: 32776380
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for linezolid-associated thrombocytopenia in adult patients.
Natsumoto B; Yokota K; Omata F; Furukawa K
Infection; 2014 Dec; 42(6):1007-12. PubMed ID: 25119433
[TBL] [Abstract][Full Text] [Related]
18. Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia.
Inoue Y; Takekuma Y; Miyai T; Kashiwagi H; Sato Y; Sugawara M; Imai S
Eur J Clin Pharmacol; 2023 Mar; 79(3):415-425. PubMed ID: 36715711
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia in Patients Receiving Prolonged Linezolid May be Caused by Oxidative Stress.
Wang TL; Guo DH; Bai Y; Wen K; Han WY; Wang R
Clin Drug Investig; 2016 Jan; 36(1):67-75. PubMed ID: 26507619
[TBL] [Abstract][Full Text] [Related]
20. Linezolid Consumption Facilitates the Development of Linezolid Resistance in
Bai B; Hu K; Zeng J; Yao W; Li D; Pu Z; Chen Z; Cheng H; Zheng J; Pan W; Lin Z; Xie L; Deng Q; Yu Z
Microb Drug Resist; 2019; 25(6):791-798. PubMed ID: 30762463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
